Connection

Jérôme de Sèze to Multiple Sclerosis, Chronic Progressive

Back to Details
This is a "connection" page, showing publications Jérôme de Sèze has written about Multiple Sclerosis, Chronic Progressive.
Jérôme de Sèze
Connection Strength
0.512
Multiple Sclerosis, Chronic Progressive
  1. Ocrelizumab for the treatment of multiple sclerosis. Expert Rev Neurother. 2019 02; 19(2):97-108.
    View in: PubMed
    Score: 0.165
  2. Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis. PLoS One. 2017; 12(1):e0168834.
    View in: PubMed
    Score: 0.144
  3. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. N Engl J Med. 2017 01 19; 376(3):209-220.
    View in: PubMed
    Score: 0.144
  4. Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients. J Neurol Sci. 2004 Mar 15; 218(1-2):73-7.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.